US2008214835A1PendingUtilityA1
Processes for preparing darifenacin hydrobromide
Assignee: TEVA PHARMACEUTICALS USA INC FPriority: Dec 27, 2005Filed: May 6, 2008Published: Sep 4, 2008
Est. expiryDec 27, 2025(expired)· nominal 20-yr term from priority
C07D 405/06C07D 207/09A61P 13/00C07D 207/48C07D 307/79
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention encompasses processes for the preparation of darifenacin hydrobromide.
Claims
exact text as granted — not AI-modified1 . N-protected-3-(S)-pyrrolidinol of the formula,
wherein X is S, SO 2 , Si, or CO, and R is phenyl, tolyl, ortho, meta, or para-xylyl, linear or branched C 1-10 alkyl, H, or CF 3 .
2 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is S and R is phenyl.
3 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is S and R is tolyl.
4 . The N-protected-3-(S)-pyrrolidinol of claim 3 , having a melting temperature of about 108° C. to about 112° C.
5 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is S and R is xylyl.
6 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is S and R is linear or branched C 1-10 alkyl.
7 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is SO 2 and R is phenyl.
8 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is SO 2 and R is tolyl.
9 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is SO 2 and R is xylyl.
10 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is SO 2 and R is linear or branched C 1-10 alkyl.
11 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is Si and R is linear or branched C 1-10 alkyl.
12 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is CO and R is H.
13 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is CO and R is CF 3 .
14 . The N-protected-3-(S)-pyrrolidinol of claim 1 , wherein X is CO and R is CH 3 .Join the waitlist — get patent alerts
Track US2008214835A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.